2616 — CStone Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- HK$1.58bn
- HK$867.01m
- CNY463.84m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,738 | 3,394 | 1,726 | 1,042 | 1,027 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 118 | 77.1 | 172 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,887 | 3,572 | 1,958 | 1,247 | 1,330 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22.2 | 102 | 188 | 207 | 153 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,951 | 3,763 | 2,271 | 1,638 | 1,662 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 458 | 727 | 933 | 946 | 850 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 469 | 808 | 1,064 | 1,189 | 1,205 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,482 | 2,954 | 1,207 | 449 | 457 |
Total Liabilities & Shareholders' Equity | 2,951 | 3,763 | 2,271 | 1,638 | 1,662 |
Total Common Shares Outstanding |